Mucosal Vaccination Against HIV-1

  • Tom Evans

Abstract

Sexual mucosal transmission of HIV-1 is the most common means of spread of HIV/AIDS throughout the world. Although it may be reasonable to assume that a vaccine that works to eliminate viral replication in the systemic lymphoid tissue may be partially protective, there is still a reasonable belief that a vaccine that engenders high level of immune defenses at mucosal surfaces will be needed in the quest for an effective HIV immunization regimen. Despite some positive advances, the fact remains that no candidate vaccine to date has elicited antibodies which can broadly neutralize a wide variety of primary HIV-1 virus isolates in humans. Moreover, the benefit of inducing either a quantitatively or qualitatively different response at the mucosal level has not been adequately addressed experimentally. Unfortunately, many of the same concerns are valid for the vaccines which have been developed to induce cytotoxic T cell responses to HIV, in an attempt to control HIV-1 replication in infected cells. Thus, all studies to date must be interpreted in the context of the failure of all human trials of HIV vaccines to date, and a lack of known correlates of immunity pending such a vaccine success.

This chapter thus focuses on non-human primate and human investigations of mucosal immunization for HIV-1. the pre-clinical evidence that mucosal routes of vaccination, or even mucosal induction of immune responses using systemic vaccination, provide complete or partial protection from HIV-1 infection or disease is evolving. Although most of the animal studies, especially in the macaque model, would imply that vaccination via the nose, rectum or vagina may be needed for optimum vaginal or rectal responses, that data is still weak and not substantiated by any human clinical trial. It is clear that we still do not know the optimum route, the desired antibody response, the qualitative or quantitative nature of the T cells and their homing markers that need to be induced, or the specific approach that will allow for development of an effective mucosal HIV vaccine. Indeed, there is still debate as to whether neutralizing antibodies or CTL or yet undefined immune parameters, either in mucosal or systemic compartments or both, may correlate with protection against infection or disease. Nonetheless, most investigators in the HIV-1 vaccine field believe that mucosal responses will be needed and may be central to eventual success.

Keywords

Placebo Chromium Tuberculosis Diarrhea Assure 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Veazey, R.S., DeMaria, M.A., Chalifoux, L.V., Shvetz, D.E., Pauley, D.R., Knight, H.L., Rosenzweig, M., Johnson, R.P., Desrosiers, R.C., and Lackner, A.A. 1998, Science, 280, 427.PubMedCrossRefGoogle Scholar
  2. 2.
    Vajdy, M., Veazey, R., Tham, I., deBakker, C., Westmoreland, S., Neutra, M., and Lackner, A. 2001, The Journal of Infectious Diseases, 184, 1007.PubMedCrossRefGoogle Scholar
  3. 3.
    Veazey, R.S. 2007, Future, 1, 103.Google Scholar
  4. 4.
    Baba, T.W., Liska, V., Hofmann-Lehmann, R., Vlasak, J., Xu, W., Ayehunie, S., Cavacini, L.A., Posner, M.R., Katinger, H., and Stiegler, G. 2000, Nature Medicine, 6, 200.PubMedCrossRefGoogle Scholar
  5. 5.
    Mascola, J.R., Stiegler, G., VanCott, T.C., Katinger, H., Carpenter, C.B., Hanson, C.E., Beary, H., Hayes, D., Frankel, S.S., and Birx, D.L. 2000, Nature Medicine, 6, 207.PubMedCrossRefGoogle Scholar
  6. 6.
    Kozlowski, P.A., and Neutra, M.R. 2003, Current Molecular Medicine, 3, 217.PubMedCrossRefGoogle Scholar
  7. 7.
    Belyakov, I.M., Ahlers, J.D., and Berzofsky, J.A. 2004, Expert Review of Vaccines, 3, S65.PubMedCrossRefGoogle Scholar
  8. 8.
    Belyakov, I.M., Ahlers, J.D., Brandwein, B.Y., Earl, P., Kelsall, B.L., Moss, B., Strober, W., and Berzofsky, J.A. 1998, Journal of Clinical Investigation, 102, 2072.PubMedCrossRefGoogle Scholar
  9. 9.
    Murphey-Corb, M., Wilson, L.A., Trichel, A.M., Roberts, D.E., Xu, K., Ohkawa, S., Woodson, B., Bohm, R., and Blanchard, J. 1999, The Journal of Immunology, 162, 540.PubMedGoogle Scholar
  10. 10.
    Lohman, B.L. 1995, The Journal of Immunology, 155, 5855.PubMedGoogle Scholar
  11. 11.
    Belyakov, I.M., Isakov, D., Zhu, Q., Dzutsev, A., and Berzofsky, J.A. 2007, The Journal of Immunology, 178, 7211.PubMedGoogle Scholar
  12. 12.
    Moldoveanu, Z., Russell, M.W., Wu, H.Y., Huang, W.Q., Compans, R.W., and Mestecky, J. 1995, Advances in Experimental Medicine and Biology, 371, 97.Google Scholar
  13. 13.
    Gallichan, W.S., and Rosenthal, K.L. 1995, Vaccine, 13, 1589.PubMedCrossRefGoogle Scholar
  14. 14.
    Johansson, E.L., Rask, C., Fredriksson, M., Eriksson, K., Czerkinsky, C., and Holmgren, J. 1998, Infection and Immunity, 66, 514.PubMedGoogle Scholar
  15. 15.
    Russell, M.W., Martin, M.H., Wu, H.Y., Hollingshead, S.K., Moldoveanu, Z., and Mestecky, J. 2000, Vaccine, 19, S122.PubMedCrossRefGoogle Scholar
  16. 16.
    Staats, H.F., Montgomery, S.P., and Palker, T.J. 1997, AIDS Research And Human Retroviruses, 13, 945.PubMedCrossRefGoogle Scholar
  17. 17.
    Imaoka, K., Miller, C.J., Kubota, M., McChesney, M.B., Lohman, B., Yamamoto, M., Fujihashi, K., Someya, K., Honda, M., and McGhee, J.R. 1998, The Journal of Immunology, 161, 5952.PubMedGoogle Scholar
  18. 18.
    Klavinskis, L.S., Barnfield, C., Gao, L., and Parker, S. 1999, The Journal of Immunology, 162, 254.PubMedGoogle Scholar
  19. 19.
    Eriksson, K., Quiding-Järbrink, M., Osek, J., Möller, Å., Björk, S., Holmgren, J., and Czerkinsky, C. 1998, Infection and Immunity, 66, 5889.PubMedGoogle Scholar
  20. 20.
    Neutra, M.R., and Kozlowski, P.A. 2006, Nature Reviews. Immunology, 6, 148.PubMedCrossRefGoogle Scholar
  21. 21.
    Kozlowski, P.A., Cu-Uvin, S., Neutra, M.R., and Flanigan, T.P. 1997, Infection and Immunity, 65, 1387.PubMedGoogle Scholar
  22. 22.
    Kozlowski, P.A., Cu-Uvin, S., Neutra, M.R., and Flanigan, T.P. 1999, The Journal of Infectious Diseases, 179, S493.PubMedCrossRefGoogle Scholar
  23. 23.
    Ogra, P.L., and Ogra, S.S. 1973, The Journal of Immunology, 110, 1307.PubMedGoogle Scholar
  24. 24.
    Waldman, R.H., Cruz, J.M., and Rowe, D.S. 1972, The Journal of Immunology, 109, 662.PubMedGoogle Scholar
  25. 25.
    O’Hagan, D.T., Rafferty, D., McKeating, J.A., and Illum, L. 1992, Journal of General Virology, 73, 2141.PubMedCrossRefGoogle Scholar
  26. 26.
    O’Hagan, D.T., Rafferty, D., Wharton, S., and Illum, L. 1993, Vaccine, 11, 660.PubMedCrossRefGoogle Scholar
  27. 27.
    Thapar, M.A., Parr, E.L., Bozzola, J.J., and Parr, M.B. 1991, Vaccine, 9, 129.PubMedCrossRefGoogle Scholar
  28. 28.
    Lu, F.X., Ma, Z., Moser, S., Evans, T.G., and Miller, C.J. 2003, Effects of Ovarian Steroids on Immunoglobulin-Secreting Cell Function in Healthy Women. pp. 944. American Society for Microbiology.Google Scholar
  29. 29.
    Challacombe, S.J., Rahman, D., and O’Hagan, D.T. 1997, Vaccine, 15, 169.PubMedCrossRefGoogle Scholar
  30. 30.
    Marx, P.A., Compans, R.W., Gettie, A., Staas, J.K., Gilley, R.M., Mulligan, M.J., Yamshchikov, G.V., Chen, D., and Eldridge, J.H. 1993, Science, 260, 1323.PubMedCrossRefGoogle Scholar
  31. 31.
    Tseng, J., Komisar, J.L., Trout, R.N., Hunt, R.E., Chen, J.Y., Johnson, A.J., Pitt, L., and Ruble, D.L. 1995, Infection and Immunity, 63, 2880.PubMedGoogle Scholar
  32. 32.
    Kubota, M. 1997, The Journal of Immunology, 158, 5321.PubMedGoogle Scholar
  33. 33.
    Van Rompay, K.K., Abel, K., Lawson, J.R., Singh, R.P., Schmidt, K.A., Evans, T., Earl, P., Harvey, D., Franchini, G., and Tartaglia, J. 2005, Journal of Acquired Immune Deficiency Syndromes, 38, 124.PubMedCrossRefGoogle Scholar
  34. 34.
    Ellenberger, D., Otten, R.A., Li, B., Aidoo, M., Rodriguez, I.V., Sariol, C.A., Martinez, M., Monsour, M., Wyatt, L., and Hudgens, M.G. 2006, Virology, 352, 216.PubMedCrossRefGoogle Scholar
  35. 35.
    McDermott, A.B., Mitchen, J., Piaskowski, S., De Souza, I., Yant, L.J., Stephany, J., Furlott, J., and Watkins, D.I. 2004, Journal of Virology, 78, 3140.PubMedCrossRefGoogle Scholar
  36. 36.
    Otten, R.A., Adams, D.R., Kim, C.N., Jackson, E., Pullium, J.K., Lee, K., Grohskopf, L.A., Monsour, M., Butera, S., and Folks, T.M. 2005, The Journal of Infectious Diseases, 191, 164.PubMedCrossRefGoogle Scholar
  37. 37.
    Marthas, M.L., Miller, C.J., Sutjipto, S., Higgins, J., Torten, J., Lohman, B.L., Unger, R.E., Ramos, R.A., Kiyono, H., and Mgghee, J.R. 1992, Journal of medical primatology, 21, 99.PubMedGoogle Scholar
  38. 38.
    Cranage, M.P., Baskerville, A., Ashworth, L.A.E., Dennis, M., Cook, N., Sharpe, S., Farrar, G., Rose, J., Kitchin, P.A., and Greenaway, P.J. 1992, Lancet (British edition), 339, 273.Google Scholar
  39. 39.
    Lehner, T., Wang, Y., Cranage, M., Bergmeier, L.A., Mitchell, E., Tao, L., Hall, G., Dennis, M., Cook, N., and Brookes, R. 1996, Nature Medicine, 2, 767.PubMedCrossRefGoogle Scholar
  40. 40.
    Lu, X., Kiyono, H., Lu, D., Kawabata, S., Torten, J., Srinivasan, S., Dailey, P.J., McGhee, J.R., Lehner, T., and Miller, C.J. 1998, AIDS, 12, 1.PubMedCrossRefGoogle Scholar
  41. 41.
    Otsyula, M.G., Miller, C.J., Tarantal, A.F., Marthas, M.L., Greene, T.P., Collins, J.R., Van Rompay, K.K.A., and McChesney, M.B. 1996, Virology, 222, 275.PubMedCrossRefGoogle Scholar
  42. 42.
    Miller, C.J., McChesney, M.B., Lu, X., Dailey, P.J., Chutkowski, C., Lu, D., Brosio, P., Roberts, B., and Lu, Y. 1997, Journal of Virology, 71, 1911.PubMedGoogle Scholar
  43. 43.
    Amara, R.R., Villinger, F., Altman, J.D., Lydy, S.L., O’Neil, S.P., Staprans, S.I., Montefiori, D.C., Xu, Y., Herndon, J.G., and Wyatt, L.S. 2001, Science, 292, 69.PubMedCrossRefGoogle Scholar
  44. 44.
    Barouch, D.H., Santra, S., Schmitz, J.E., Kuroda, M.J., Fu, T.M., Wagner, W., Bilska, M., Craiu, A., Zheng, X.X., and Krivulka, G.R. 2000, Science, 290, 486.PubMedCrossRefGoogle Scholar
  45. 45.
    Rose, N.F., Marx, P.A., Luckay, A., Nixon, D.F., Moretto, W.J., Donahoe, S.M., Montefiori, D., Roberts, A., Buonocore, L., and Rose, J.K. 2001, Cell, 106, 539.PubMedCrossRefGoogle Scholar
  46. 46.
    Pal, R., Venzon, D., Santra, S., Kalyanaraman, V.S., Montefiori, D.C., Hocker, L., Hudacik, L., Rose, N., Nacsa, J., and Edghill-Smith, Y. 2006, Journal of Virology, 80, 3732.PubMedCrossRefGoogle Scholar
  47. 47.
    Gomez-Roman, V.R., and Robert-Guroff, M. 2003, AIDS AIDS Reviews, 5, 178.Google Scholar
  48. 48.
    Santosuosso, M., McCormick, S., and Xing, Z. 2005, Viral Immunology, 18, 283.PubMedCrossRefGoogle Scholar
  49. 49.
    Buge, S.L., Richardson, E., Alipanah, S., Markham, P., Cheng, S., Kalyan, N., Miller, C.J., Lubeck, M., Udem, S., and Eldridge, J. 1997, Journal of Virology, 71, 8531.PubMedGoogle Scholar
  50. 50.
    Patterson, L.J., Malkevitch, N., Venzon, D., Pinczewski, J., Gomez-Roman, V.R., Wang, L., Kalyanaraman, V.S., Markham, P.D., Robey, F.A., and Robert-Guroff, M. 2004, Journal of Virology, 78, 2212.PubMedCrossRefGoogle Scholar
  51. 51.
    Egan, M.A., Chong, S.Y., Rose, N.F., Megati, S., Lopez, K.J., Schadeck, E.B., Johnson, J.E., Masood, A., Piacente, P., and Druilhet, R.E. 2004, AIDS Research and Human Retroviruses, 20, 989.PubMedCrossRefGoogle Scholar
  52. 52.
    Belyakov, I.M., Hel, Z., Kelsall, B., Kuznetsov, V.A., Ahlers, J.D., Nacsa, J., Watkins, D.I., Allen, T.M., Sette, A., and Altman, J. 2001, Nature Medicine, 7, 1320.PubMedCrossRefGoogle Scholar
  53. 53.
    Belyakov, I.M., Kuznetsov, V.A., Kelsall, B., Klinman, D., Moniuszko, M., Lemon, M., Markham, P.D., Pal, R., Clements, J.D., and Lewis, M.G. 2006, Blood, 107, 3258.PubMedCrossRefGoogle Scholar
  54. 54.
    Crotty, S., and Andino, R. 2004, Advanced Drug Delivery Reviews, 56, 835.PubMedCrossRefGoogle Scholar
  55. 55.
    Crotty, S., Miller, C.J., Lohman, B.L., Neagu, M.R., Compton, L., Lu, D., Lu, F.X.S., Fritts, L., Lifson, J.D., and Andino, R. 2001, Journal of Virology, 75, 7435.PubMedCrossRefGoogle Scholar
  56. 56.
    Lundholm, P., Leandersson, A.C., Christensson, B., Bratt, G., Sandström, E., and Wahren, B. 2001, Virus Research, 82, 141.CrossRefGoogle Scholar
  57. 57.
    Belyakov, I.M., Hammond, S.A., Ahlers, J.D., Glenn, G.M., and Berzofsky, J.A. 2004, Journal of Clinical Investigation, 113, 998.PubMedGoogle Scholar
  58. 58.
    Lambert, J.S., Keefer, M., Mulligan, M.J., Schwartz, D., Mestecky, J., Weinhold, K., Smith, C., Hsieh, R., Moldoveanu, Z., and Fast, P. 2001, Vaccine, 19, 3033.PubMedCrossRefGoogle Scholar
  59. 59.
    Gorse, G.J., Keefer, M.C., Belshe, R.B., Matthews, T.J., Forrest, B.D., Hsieh, R.H., Koff, W.C., Hanson, C.V., Dolin, R., and Weinhold, K.J. 1996, J Infect Dis, 173, 330.PubMedGoogle Scholar
  60. 60.
    Wahl, S.M., Smith, P.D., and Janoff, E.N. 1999, J. infect. Dis, 179, S397.PubMedCrossRefGoogle Scholar
  61. 61.
    Wright, P.F., Mestecky, J., McElrath, M.J., Keefer, M.C., Gorse, G.J., Goepfert, P.A., Moldoveanu, Z., Schwartz, D., Spearman, P.W., and El-Habib, R. 2004, The Journal of Infectious Diseases, 189, 1221.PubMedCrossRefGoogle Scholar
  62. 62.
    Kotton, C.N., Lankowski, A.J., Scott, N., Sisul, D., Chen, L.M., Raschke, K., Borders, G., Boaz, M., Spentzou, A., and Galán, J.E. 2006, Vaccine, 24, 6216.PubMedCrossRefGoogle Scholar
  63. 63.
    Belyakov, I.M., and Berzofsky, J.A. 2004, Immunity, 20, 247.PubMedCrossRefGoogle Scholar
  64. 64.
    Musey, L., Ding, Y., Elizaga, M., Ha, R., Celum, C., and McElrath, M.J. 2003, The Journal of Immunology, 171, 1094.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2008

Authors and Affiliations

  • Tom Evans
    • 1
  1. 1.Novartis Institute of Biomedical ResearchCambridgeUSA

Personalised recommendations